Abstract
The genomic alterations, somatic interactions, traditional serum biomarkers, and heavy metals were different between patients with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). This study suggests that heavy metals (e.g., Ba, Pb, and Cd) may contribute to the tumorigenesis of non-small cell lung cancer (NSCLC) with different histological and molecular subtypes.
Introduction
Non-small cell lung cancer (NSCLC) is characterized by significant heterogeneity, primarily divided into lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). While the genetic drivers of these subtypes are well-documented—such as EGFR mutations in LUAD and PIK3CA alterations in LUSC—the environmental factors influencing these distinct molecular pathways are less understood. This research investigates the correlation between serum heavy metal concentrations and specific genomic mutations to elucidate how environmental exposures might shape the genetic landscape of lung tumors.
Genomic Landscape of LUAD and LUSC
The study analyzed 180 patients, identifying somatic mutations in 77.7% of LUAD cases and 75% of LUSC cases using a targeted 82-gene Next-Generation Sequencing (NGS) panel. The mutation profiles revealed subtype-specific patterns in tumor tissue samples.
In LUAD tissue, TP53 and EGFR were the most frequently mutated genes. In contrast, LUSC tissue showed a high prevalence of TP53 mutations but a different distribution of secondary drivers like PIK3CA and RB1.
Heavy Metal Signatures and Mutation Correlations
A key finding of the study is the identification of "metal-mutation" signatures. Using Inductively Coupled Plasma Mass Spectrometry (ICP-MS), researchers measured 18 heavy metals in patient serum.
- Barium (Ba): LUSC patients exhibited significantly higher median serum Ba concentrations (50.88 μg/L) compared to LUAD patients (36.27 μg/L), suggesting a potential role for Barium in squamous cell tumorigenesis.
- Cadmium (Cd) and Strontium (Sr): EGFR mutations, typically found in non-smoking female LUAD patients, were negatively correlated with Cd and Sr levels. Median Cd was 0.29 μg/L in EGFR-positive patients versus 0.48 μg/L in EGFR-negative patients.
- Lead (Pb): TP53 mutations showed a significant positive correlation with serum Lead levels, indicating that Lead exposure might be associated with the genomic instability characterized by TP53 loss.
These correlations suggest that environmental heavy metals are not just passive contaminants but may actively interact with or select for specific oncogenic pathways.
Consistency Between Tissue and Liquid Biopsy
The study also compared the mutation profiles of tumor tissue DNA and plasma ctDNA. The consistency of mutation detection varied significantly between histological subtypes.
LUAD patients showed a higher consistency (40%) between ctDNA and tissue DNA compared to LUSC patients (26.67%). This difference highlights the varying biological characteristics of these tumors, such as their propensity to shed DNA into the peripheral blood, which has implications for the clinical utility of liquid biopsies in different NSCLC subtypes.
Conclusion and Future Directions
This study provides evidence that heavy metal exposure is linked to the specific genomic alterations driving NSCLC. While the findings are compelling, the authors note limitations including a relatively small LUSC cohort and the use of serum for metal measurement, which reflects recent rather than chronic exposure. Future research utilizing hair or nail samples for long-term exposure assessment and larger, multi-center cohorts will be essential to validate these environmental-genomic interactions.
Summary updated